SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.48%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$15.3M
AUM Growth
+$15.3M
(+35%)
Cap. Flow
-$1.74M
Cap. Flow
% of AUM
-11.36%
Top 10 Holdings %
Top 10 Hldgs %
76.86%
Holding
79
New
23
Increased
4
Reduced
14
Closed
26
Top Buys
| 1 |
Vivani Medical
VANI
|
$4.95M |
| 2 |
Eltek
ELTK
|
$1.26M |
| 3 |
RDHL
Redhill Biopharma
RDHL
|
$1.23M |
| 4 |
Global Mofy Metaverse
GMM
|
$528K |
| 5 |
China Natural Resources
CHNR
|
$511K |
Top Sells
| 1 |
FMTO
Femto Technologies Inc. Common Stock
FMTO
|
$4.19M |
| 2 |
TC
TuanChe
TC
|
$2.62M |
| 3 |
MMAT
Meta Materials Inc. Common Stock
MMAT
|
$904K |
| 4 |
Phunware
PHUN
|
$821K |
| 5 |
iBio
IBIO
|
$661K |
Sector Composition
| 1 | Healthcare | 64.01% |
| 2 | Technology | 14.05% |
| 3 | Industrials | 7.56% |
| 4 | Energy | 2.75% |
| 5 | Materials | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vivani Medical
VANI
$68.1M
| $4.95M | 2.85% | +2,673,018 | New | +$4.95M |
|
|
2
Eltek
ELTK
$69.1M
| $1.26M | 0.73% | +113,000 | New | +$1.26M |
|
|
RDHL
3
Redhill Biopharma
RDHL
$3.1M
| $1.23M | 0.71% | +2,319,238 | New | +$1.23M |
|
4
Tonix Pharmaceuticals
TNXP
$260M
| $911K | 0.53% | 4,895,962 +1,800,321 | +58% | +$335K |
|
|
5
Global Mofy Metaverse
GMM
$64.9M
| $528K | 0.3% | +641,078 | New | +$528K |
|
|
6
China Natural Resources
CHNR
$4.64M
| $511K | 0.29% | +429,191 | New | +$511K |
|
7
Recon Technology
RCON
$64.6M
| $420K | 0.24% | 2,840,592 -609,050 | -18% | -$90.1K |
|
8
BioVie
BIVI
$11.5M
| $364K | 0.21% | +689,135 | New | +$364K |
|
|
NEXI
9
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $336K | 0.19% | +59,851 | New | +$336K |
|
|
AUVI
10
DELISTED
Applied UV, Inc. Common Stock
AUVI
| $323K | 0.19% | +217,084 | New | +$323K |
|
11
Sidus Space
SIDU
$32.1M
| $282K | 0.16% | +83,100 | New | +$282K |
|
12
Gevo
GEVO
$418M
| $269K | 0.16% | 350,000 -13,029 | -4% | -$10K |
|
13
BioRestorative Therapies
BRTX
$14.7M
| $233K | 0.13% | +168,544 | New | +$233K |
|
|
SUNE
14
SUNation Energy, Inc. Common Stock
SUNE
$5.08M
| $231K | 0.13% | +3,400,134 | New | +$231K |
|
15
TransCode Therapeutics
RNAZ
$8.11M
| $229K | 0.13% | +334,823 | New | +$229K |
|
16
GlucoTrack
GCTK
$3.8M
| $204K | 0.12% | 614,636 +185,728 | +43% | +$61.5K |
|
17
Ensysce Biosciences
ENSC
$6.2M
| $182K | 0.11% | +230,554 | New | +$182K |
|
|
LIPO
18
DELISTED
Lipella Pharmaceuticals
LIPO
| $171K | 0.1% | 249,899 -19,930 | -7% | -$13.7K |
|
19
Bluejay Diagnostics
BJDX
$2.03M
| $150K | 0.09% | 187,293 +37,367 | +25% | +$30K |
|
20
InMed Pharmaceuticals
INM
$4.44M
| $132K | 0.08% | 361,728 -150,206 | -29% | -$54.7K |
|
|
SCNI
21
Scinai Immunotherapeutics
SCNI
$1.53M
| $131K | 0.08% | 253,135 +32,472 | +15% | +$16.9K |
|
|
FMTO
22
DELISTED
Femto Technologies Inc. Common Stock
FMTO
| $129K | 0.07% | 92,420 -2,994,404 | -97% | -$4.19M |
|
23
Processa Pharmaceuticals
PCSA
$9.52M
| $115K | 0.07% | +48,601 | New | +$115K |
|
|
ATXI
24
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $99K | 0.06% | +670,926 | New | +$99K |
|
|
BCTX
25
Briacell Therapeutics
BCTX
$13.6M
| $97.9K | 0.06% | +34,222 | New | +$97.9K |
|